This site is intended for healthcare professionals
CSU Learning Zone
Declaration of sponsorship Novartis AG and J. Uriach y Compañía S.A

EADV Virtual 2020

Declaration of sponsorship Novartis AG and J. Uriach y Compañía S.A
Read time: 40 mins
Last updated:16th Nov 2020
Published:29th Oct 2020
Explore this section for the latest updates in chronic spontaneous urticaria treatment and management from the European Academy of Dermatology and Venereology (EADV) International Congress 2020 Virtual, including an expert summary interview with Professor Marcus Maurer.

These blogs and interview have been developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content.

EADV Virtual

It’s time for EADV virtual, the 29th European Academy of Dermatology and Venereology (EADV) congress that explores new frontiers in dermatology and venereology. In these blog posts, we want to show you some of the exciting sessions on chronic spontaneous urticaria that are being discussed at EADV 2020. Find out more below.

Register free for full access to medthority.com

Gain insight into the diagnosis and management of chronic spontaneous urticaria (CSU) as well as the impact of the COVID-19 pandemic in the sessions below from EADV virtual 2020.

Day one of the European Academy of Dermatology and Venereology (EADV) Virtual Congress 2020 was packed with a range of fascinating sessions on chronic spontaneous urticaria.

Register free for full access to medthority.com

Explore the exciting research area of phenotypes, biomarkers and targeting the wheal in chronic spontaneous urticaria in the sessions below from EADV virtual 2020.

Day two of the European Academy of Dermatology and Venereology (EADV) Virtual Congress 2020 gave thought-provoking updates on a wide range of areas in chronic spontaneous urticaria.

Register free for full access to medthority.com

Day three – exploring study outcomes for CSU

See the results of studies on chronic urticaria during pregnancy, the prevalence and predictors of angioedema, and comparing ligelizumab and omalizumab in the sessions below from EADV virtual 2020.

Register free for full access to medthority.com

Too busy to make it to EADV virtual 2020? Don’t worry, find out about the best sessions and ePosters that came up over the three days in our brief recap below.

Sessions on chronic spontaneous urticaria (CSU) were an unmissable experience at the European Academy of Dermatology and Venereology (EADV) Virtual Congress 2020.

Register free for full access to medthority.com

We catch up with Professor Marcus Maurer who reflects on the highlights of this year’s EADV Virtual Congress and discusses what the future may hold for the patients with chronic urticaria.

Register free for full access to medthority.com

Welcome: